TMO

Thermo Fisher raises bid for Qiagen to 43 eur/shr

Credit: REUTERS/Henry Nicholls

BERLIN, July 16 (Reuters) - Thermo Fisher Scientific TMO.N said on Thursday it had decided to raise its bid for Qiagen QIA.DE to 43 euros ($49.06) per share to reflect the German genetic test maker's improved business prospects since the coronavirus pandemic.

Thermo Fisher's cash offer represents a 35% premium to Qiagen's closing price on March 2, the two companies said in a statement.

($1 = 0.8764 euros)

(Reporting by Caroline Copley Editing by Michelle Martin)

((Caroline.Copley@thomsonreuters.com; +49 30 2888 5214; Reuters Messaging: caroline.copley.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.